Skip to main content

David Penson Archives

VU to lead prostate cancer treatment research effort

May. 23, 2013—David Penson, M.D., MPH, professor of Urologic Surgery, has received a $2 million research award from the Patient-Centered Outcomes Research Institute (PCORI) to study localized prostate cancer, the second leading cause of death among American men.

Read more


Long-term effects of prostate therapies tracked

Jan. 30, 2013—A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment.

Read more


Vanderbilt-led study reveals racial disparities in prostate cancer care

Aug. 30, 2012—Racial differences exist in quality surgical care, new research from VICC finds.

Read more


Mixed results define 2012 Tennessee Men’s Health Report Card

Jun. 12, 2012—Heart disease is still the leading cause of death for men in Tennessee and cancer deaths continue to move further away from the Centers for Disease Control and Prevention’s Healthy People 2020 goal, according to the 2012 Tennessee Men’s Health Report Card.

Read more


Page 2 of 212